Related Experiment Video
Updated: Sep 6, 2025
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Hepatic granuloma-A diagnostic challenge]
Ludwig J Horst1,2, Sören Weidemann3, Ansgar W Lohse1,2
1I. Medizinische Klinik und Poliklinik, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.
Insights
Diagnosing hepatic granulomas involves assessing risk factors and ruling out other conditions. A liver biopsy is crucial for confirmation, with treatment depending on the underlying cause and liver damage.
Area of Science:
- Hepatology
- Immunology
- Pathology
Background:
- Hepatic granulomas are inflammatory collections in the liver with diverse etiologies.
- Systematic evaluation is necessary for accurate diagnosis and management.
- Common causes in Germany include primary biliary cholangitis, sarcoidosis, tuberculosis, and hepatitis C.
Purpose of the Study:
- To outline a diagnostic approach for hepatic granulomas.
- To emphasize the importance of identifying underlying causes and assessing disease severity.
- To guide therapeutic strategies based on clinical presentation and biopsy findings.
Main Methods:
- Initial assessment includes identifying risk factors and excluding extrahepatic manifestations.
- Laboratory investigations and serological screening for common etiologies.
- Minilaparoscopically guided liver biopsy for definitive diagnosis and macroscopic evaluation.
Main Results:
- A systematic diagnostic pathway is essential for hepatic granulomas.
- Liver biopsy, particularly when guided by minilaparoscopy, aids in macroscopic detection and diagnosis.
- Treatment decisions are contingent upon the identified underlying disease and presence of liver damage.
Conclusions:
- Hepatic granulomas necessitate a comprehensive diagnostic workup.
- Minilaparoscopic liver biopsy offers advantages for diagnosis.
- Management strategies range from 'watch and wait' to prompt treatment of the primary condition, guided by clinical and laboratory monitoring.
Abstract:
Hepatic granulomas can have various causes and their detection requires a systematic diagnostic evaluation. First, identification of risk factors for granulomatous diseases and the exclusion of extrahepatic organ manifestation are necessary. Laboratory investigations and serological screening for the most common underlying diseases of liver granulomas in Germany, such as primary biliary cholangitis (PBC), sarcoidosis and infectious causes (primarily tuberculosis and hepatitis C infections), are recommended. A liver biopsy is essential for confirming the diagnosis, whereby a minilaparoscopically guided tissue sampling offers many advantages, such as the macroscopic detection of granulomas on the liver surface, on the peritoneum or on the spleen. Whether the detection of hepatic granulomas results in a therapeutic consequence, depends decisively on the underlying primary disease. If hepatic granulomas are present without concomitant liver parenchymal damage or other manifestations that would make treatment necessary, a watch and wait approach under close clinical and laboratory monitoring is sufficient. If liver values increase or in cases of hepatic parenchymal damage, urgent treatment of the underlying disease is indicated.
